1. Home
  2. MREO vs HDRN Comparison

MREO vs HDRN Comparison

Compare MREO & HDRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

SELL

Current Price

$0.30

Market Cap

50.3M

Sector

Health Care

ML Signal

SELL

Logo Hadron Energy Inc. Common Stock

HDRN

Hadron Energy Inc. Common Stock

HOLD

Current Price

$0.54

Market Cap

47.2M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
MREO
HDRN
Founded
2015
2024
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
50.3M
47.2M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
MREO
HDRN
Price
$0.30
$0.54
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $1.96
N/A
AVG Volume (30 Days)
★ 632.5K
139.5K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 16.67
N/A
EPS
★ N/A
N/A
Revenue
★ $500,000.00
N/A
Revenue This Year
$59.51
N/A
Revenue Next Year
$2,326.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.56
52 Week High
$2.37
$2.67

Technical Indicators

Market Signals
Indicator
MREO
HDRN
Relative Strength Index (RSI) 50.90 27.15
Support Level $0.27 N/A
Resistance Level $0.35 $0.94
Average True Range (ATR) 0.02 0.09
MACD 0.00 0.01
Stochastic Oscillator 62.55 1.85

Price Performance

Historical Comparison
MREO
HDRN

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About HDRN Hadron Energy Inc. Common Stock

Hadron Energy Inc is a nuclear technology company focused on developing factory-fabricated, transportable 10 megawatt-electric (MWe) micro-modular reactors (MMRs) to meet the growing demand for clean, reliable, and affordable power. The company aims to deliver scalable, carbon-free energy solutions that can be rapidly deployed to power a variety of industries, including data centers, industrial facilities, remote communities, government installations and more. The market segments for its proprietary reactor, Hadron Halos, are Data Centers, Industrial Facilities and Heavy Manufacturing, Remote Communities and Critical Infrastructure, and Utilities and Distributed Energy.

Share on Social Networks: